Filing Details
- Accession Number:
- 0001104659-20-029361
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-04 18:39:54
- Reporting Period:
- 2020-03-02
- Accepted Time:
- 2020-03-04 18:39:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 3116 | Akorn Inc | AKRX | Pharmaceutical Preparations (2834) | 720717400 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1124179 | J Steven Meyer | C/O Akorn, Inc. 1925 W. Field Court, Suite 300 Lake Forest IL 60045 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-03-03 | 15,000 | $0.99 | 145,225 | No | 4 | P | Indirect | Reporting Person trust |
| Common Stock | Acquisiton | 2020-03-02 | 85,000 | $1.08 | 130,225 | No | 4 | P | Indirect | Reporting Person trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Reporting Person trust |
| No | 4 | P | Indirect | Reporting Person trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 138,154 | Direct | |
| Common Stock | 10,210 | Indirect | Spouse trust |
| Common Stock | 1,250 | Indirect | Child's trust |
| Common Stock | 1,250 | Indirect | Child's trust |
| Common Stock | 1,250 | Indirect | Child's trust |
Footnotes
- Represents the weighted average purchase price of the shares purchased. The shares were purchased at prices ranging from $0.95 to $1.01. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at separate prices within the foregoing range.
- The Reporting Person is a trustee of this family trust.
- Represents the weighted average purchase price of the shares purchased. The shares were purchased at prices ranging from $1.05 to $1.10. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at separate prices within the foregoing range.
- The amount of shares beneficially owned includes 45,445 unvested Restricted Stock Units (RSUs) and 92,709 shares owned outright.
- This trust is held for the benefit of a child of the Reporting Person.
Billionaire Hedge Funds
